Search arXiv⌕ Search
Home/Archive/arXiv

arXiv · 2610.35186

Gold nanorods targeting tumor vasculature: Monte Carlo evaluation of the radioenhancement effects

Ali Taheri·Hans Rabus·Mayeen Uddin Khandaker·Farhad Moradi·David Andrew Bradley
View original source ↗Read source document ↗Export metadata ↓

Abstract

Gold nanoparticles targeted to tumor vasculature can raise the dose to endothelial cells, and the enhancement depends on their position relative to the vessel wall. Despite growing interest in endothelial radiosensitization, intravascular and immediate perivascular dose enhancement has not been resolved at the level of individual endothelial cells for different nanoparticle locations. Earlier vascular dosimetry scored thin wall layers, analytic endothelial slabs, or tissue-region averages. This study quantifies the dose enhancement ratio (DER) of gold nanorods (AuNRs) in individual endothelial cells and in the perivascular region for three AuNR locations. Track-structure Monte Carlo simulations in TOPAS modeled a 10 um long, 16 um diameter microvessel segmented into six endothelial cells. AuNRs were placed homogeneously in the lumen, on the inner vessel wall (vascular-targeted), or on the outer vessel wall (extravasated) at concentrations of 5 to 50 mg Au/g water within the vessel volume under 50 and 100 kVp X-rays. All DERs were corrected for the lack of charged-particle equilibrium (CPE) inherent to microscale simulations. Inner wall-attached AuNRs produced the highest microvessel-averaged DERs, reaching approximately 3.8 at 50 mg Au/g water and approximately 1.96 at 18 mg Au/g water under 50 kVp. The DER increased linearly with AuNR concentration and was higher at 50 kVp than at 100 kVp. Including AuNRs outside the simulated segment (infinite vessel approximation) increased endothelial DERs by 5 to 10 percent. In the perivascular region, the DER was highest within the first 10 um, where outer wall-attached AuNRs gave the highest values. The results establish a physical dose enhancement basis for endothelial and perivascular cells and can guide the design of vascular-targeted radiosensitization.

Explore related subjects

physics.med-ph

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ali Taheri, Hans Rabus, Mayeen Uddin Khandaker, Farhad Moradi, David Andrew Bradley. 2026-10-26. Gold nanorods targeting tumor vasculature: Monte Carlo evaluation of the radioenhancement effects. https://arxiv.org/abs/2610.35186

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

arXiv2026

Just-in-time volumetric imaging: Learning 2D-3D thoracic motion models during image-guided interventions

Despite two decades of innovation, cutting-edge bronchoscopic techniques still fail to yield clear diagnostic decisions in 30% of cases and miss malignancies in 20% of cases. Intraprocedural 3D imaging drastically improves both tool positioning and diagnostic yield. However, each 3D spin represents a static snapshot of an anatomy that is continuously evolving as the patient is ventilated throughout the procedure. Here, we propose just-in-time volumetric imaging, in which a patient-specific 2D--3D motion model is trained on pre-intervention scans before it is needed and then supplies volumetric images from single fluoroscopic projections during sampling. Given the inspiration-hold CBCT already acquired for navigation and an additional motion-inclusive CBCT, our optimization regime named VoxelMap-DualScan (VM-DS), solves a low-rank motion model by alternating least squares and then amortizes it into a projection encoder trained on synthesized projections with known motion, all within a 10-minute window. On eight held-out cases from the public DIR-Lab 4DCT dataset, VM-DS achieved a mean landmark target registration error of 2.8 mm, a structural similarity index of 0.95 and a peak signal-to-noise ratio of 37.6 dB. Accuracy was maintained when reducing the number of projections used for training from 227 to 57. Inference takes 1.5 ms per projection, making the framework suitable for real-time use during image-guided interventions. Code will be made available at https://github.com/Image-X-Institute/Voxelmap/tree/VM-DS

physics.med-ph↗
arXiv2026

At last, an explicit singular value decomposition for electrical impedance tomography

We derive a diagonalization of the normal operator of the linearized electrical impedance tomography (EIT) problem on the disk in the case of a radially symmetric Schrödinger potential with Dirichlet-to-Neumann data. The diagonalization is achieved by transforming the normal operator to the adjacent interval finite Hilbert transform which has a known spectral theory including a commuting differential operator. The normal operator in this case is not compact and the spectrum continuous.

physics.med-ph↗
arXiv2026

Angle-Dependent Dose Transformer Algorithm for Fast Proton Therapy Dose Calculations

Monte Carlo (MC) dose engines are the gold standard for pencil beam scanning proton therapy, but their computational cost limits adaptive workflows and other tasks requiring repeated dose recalculation. Existing deep learning beamlet dose engines require each beamlet to be sampled in its beam's-eye-view, which implies a local resampling of the computed tomography (CT) patch for every beamlet. We propose the Angle-dependent Dose Transformer Algorithm (ADoTA), which adds an input channel encoding a fast analytical beamlet shape projection that supplies the beam direction explicitly. The CT is resampled only once per irradiation field to an isotropic $2\times2\times2$ mm$^3$ grid, and each beamlet is obtained by cropping this shared grid. The model was trained on CT data from 108 patients for initial energies of 70 to 150 MeV (thoracic) and 70 to 270 MeV (abdominal/pelvic) and evaluated on an independent test cohort of 50 patients. ADoTA achieved $Γ(1\%,3\,\mathrm{mm},0.1\%)$ pass rates of $99.40\pm0.86\%$ (thoracic) and $99.87\pm0.23\%$ (abdominal/pelvic), with an effective batched throughput of $3.14\pm0.31$ ms per beamlet. In a 5640-spot prostate plan benchmark with both routes optimized on the GPU, the analytical projection reduced the plan's direction-encoding cost by $9.6\times$ and its total compute time by $1.48\times$ compared with local beam's-eye-view sampling. For full treatment plans, $Γ(2\%,2\,\mathrm{mm},10\%)$ pass rates averaged 95.1% (lung) and 96.1% (prostate), while the target $D_{98\%}$ was underestimated by 1.8 to 2.5% of prescription in prostate plans and 4.2 to 5.9% in thoracic plans. ADoTA achieves close to MC accuracy at the beamlet level without beamlet-specific resampling, with a clinically relevant target underdosage in thoracic plans that should be resolved before clinical use.

physics.med-ph↗